{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:32:41Z","timestamp":1793705561918,"version":"4.5.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.vaccine.2004.07.025","type":"journal-article","created":{"date-parts":[[2004,8,26]],"date-time":"2004-08-26T19:32:12Z","timestamp":1093548732000},"page":"755-761","source":"Crossref","is-referenced-by-count":36,"title":["The burden and cost of hospitalised varicella and zoster in Australian children"],"prefix":"10.1016","volume":"23","author":[{"given":"Jonathan R.","family":"Carapetis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.F.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.vaccine.2004.07.025_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2004.07.025_bib2","unstructured":"Australian Technical Advisory Group on Immunisation. Australian Immunisation Handbook, 8th edition, Commonwealth Department of Health and Ageing, Canberra, 2003."},{"issue":"10","key":"10.1016\/j.vaccine.2004.07.025_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.88.10.862","article-title":"Varicella vaccination in England and Wales: cost-utility analysis","volume":"88","author":"Brisson","year":"2003","journal-title":"Arch. Dis. Childhood"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2004.07.025_bib4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(02)00431-0","article-title":"The cost-effectiveness of routine childhood varicella vaccination in Germany","volume":"21","author":"Banz","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.025_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00430-002-0123-4","article-title":"Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany","volume":"191","author":"Wutzler","year":"2002","journal-title":"Med. Microbiol. Immunol. (Berlin)"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.025_bib6","first-page":"249","article-title":"The cost-effectiveness of varicella vaccination in Canada","volume":"61","author":"Naesens","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.vaccine.2004.07.025_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/hec.694","article-title":"Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination","volume":"11","author":"Hall","year":"2002","journal-title":"Health Econ."},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.025_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00006454-200206000-00012","article-title":"Instituting a routine varicella vaccination program in Canada: an economic evaluation","volume":"21","author":"Getsios","year":"2002","journal-title":"Pediatric Infectious Dis. J."},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2004.07.025_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0264-410X(99)00261-3","article-title":"The cost-effectiveness of varicella vaccine programs for Australia","volume":"18","author":"Scuffham","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.025_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0277-9536(99)00115-X","article-title":"The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule","volume":"49","author":"Scuffham","year":"1999","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.vaccine.2004.07.025_bib11","unstructured":"Anonymous. Development of the cost weights and WIES. In: Victoria \u2014 public hospitals and mental health services policy and funding guidelines 2002\u20132003. Melbourne: Victorian Government Department of Human Services; 2002, p. 66\u201370."},{"key":"10.1016\/j.vaccine.2004.07.025_bib12","unstructured":"Australian Technical Advisory Group on Immunisation. Australian immunisation handbook, 7th ed., Canberra: Commonwealth Department of Health and Ageing; 2000."},{"issue":"15","key":"10.1016\/j.vaccine.2004.07.025_bib13","first-page":"125","article-title":"The Immunization Monitoring Program-active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian children: 1991\u20131996","volume":"26","author":"Law","year":"2000","journal-title":"Can. Communicable Dis. Rep."},{"issue":"4","key":"10.1016\/j.vaccine.2004.07.025_bib14","first-page":"397","article-title":"Complicaciones en ninos con varicela en cuatro hospitales de Santiago-Chile: espectro clinico y estimacion de costos directos","volume":"129","author":"Abarca","year":"2001","journal-title":"Revista Medica de Chile"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.025_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00006454-199602000-00011","article-title":"Invasive group A streptococcal infections in children with varicella in Southern California","volume":"15","author":"Vugia","year":"1996","journal-title":"Pediatric Infectious Dis. J."},{"key":"10.1016\/j.vaccine.2004.07.025_bib16","unstructured":"Anonymous. Outbreak of invasive group A Streptococcus associated with varicella in a childcare center \u2014 Boston, Massachusetts, 1997. MMWR \u2013 Morbidity & Mortality Weekly Report 1997, 46(40), 944\u2013948."},{"issue":"5","key":"10.1016\/j.vaccine.2004.07.025_bib17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1542\/peds.107.5.1108","article-title":"Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella","volume":"107","author":"Lesko","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2004.07.025_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1467-842X.1998.tb01405.x","article-title":"Varicella-zoster virus infection in Australia. [erratum appears in Aust N Z J Public Health 1998 Aug;22(5):630]","volume":"22","author":"Chant","year":"1998","journal-title":"Aust. New Zealand J. Public Health"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2004.07.025_bib19","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/jmv.10317","article-title":"Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV","volume":"70","author":"Brisson","year":"2003","journal-title":"J. Med. Virol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04005729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04005729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T11:21:35Z","timestamp":1549279295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04005729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0264410X04005729"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.07.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}